BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 31899695)

  • 1. Biological Mechanisms of Atropine Control of Myopia.
    Upadhyay A; Beuerman RW
    Eye Contact Lens; 2020 May; 46(3):129-135. PubMed ID: 31899695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical Atropine in the Control of Myopia.
    Tan D; Tay SA; Loh KL; Chia A
    Asia Pac J Ophthalmol (Phila); 2016; 5(6):424-428. PubMed ID: 27898446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atropine for the treatment of childhood myopia.
    Chua WH; Balakrishnan V; Chan YH; Tong L; Ling Y; Quah BL; Tan D
    Ophthalmology; 2006 Dec; 113(12):2285-91. PubMed ID: 16996612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myopia Control: A Review.
    Walline JJ
    Eye Contact Lens; 2016 Jan; 42(1):3-8. PubMed ID: 26513719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Dose Atropine in Preventing the Progression of Childhood Myopia: A Randomised Controlled Trial.
    Sharma I; Das GK; Rohatgi J; Sahu PK; Chhabra P; Bhatia R
    Curr Eye Res; 2023 Apr; 48(4):402-407. PubMed ID: 36576170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of myopia progression with 0.05% atropine solution.
    Lee JJ; Fang PC; Yang IH; Chen CH; Lin PW; Lin SA; Kuo HK; Wu PC
    J Ocul Pharmacol Ther; 2006 Feb; 22(1):41-6. PubMed ID: 16503774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of atropine 1% in children with low myopia.
    Yi S; Huang Y; Yu SZ; Chen XJ; Yi H; Zeng XL
    J AAPOS; 2015 Oct; 19(5):426-9. PubMed ID: 26228967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atropine, 0.01%, for Myopia Control.
    Walline JJ; Berntsen DA
    JAMA Ophthalmol; 2023 Aug; 141(8):766-767. PubMed ID: 37440252
    [No Abstract]   [Full Text] [Related]  

  • 9. Interventions to slow progression of myopia in children.
    Walline JJ; Lindsley K; Vedula SS; Cotter SA; Mutti DO; Twelker JD
    Cochrane Database Syst Rev; 2011 Dec; (12):CD004916. PubMed ID: 22161388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atropine for the Treatment of Childhood Myopia in India: Multicentric Randomized Trial.
    Saxena R; Dhiman R; Gupta V; Kumar P; Matalia J; Roy L; Swaminathan M; Phuljhele S; Velpandian T; Sharma N
    Ophthalmology; 2021 Sep; 128(9):1367-1369. PubMed ID: 33545170
    [No Abstract]   [Full Text] [Related]  

  • 11. The Role of Atropine Eye Drops in Myopia Control.
    Grzybowski A; Armesto A; Szwajkowska M; Iribarren G; Iribarren R
    Curr Pharm Des; 2015; 21(32):4718-30. PubMed ID: 26350533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Concentration Atropine Eyedrops for Myopia in Children.
    Tsuda H; Someko H; Kataoka Y
    JAMA; 2023 Jun; 329(21):1885-1886. PubMed ID: 37278817
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-Concentration Atropine Eyedrops for Myopia in Children-Reply.
    Zhang XJ; Zhang Y; Yam JC
    JAMA; 2023 Jun; 329(21):1886. PubMed ID: 37278815
    [No Abstract]   [Full Text] [Related]  

  • 14. How does atropine exert its anti-myopia effects?
    McBrien NA; Stell WK; Carr B
    Ophthalmic Physiol Opt; 2013 May; 33(3):373-8. PubMed ID: 23662969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The control of myopia with atropine.
    Gimbel HV
    Can J Ophthalmol; 1973 Oct; 8(4):527-32. PubMed ID: 4751898
    [No Abstract]   [Full Text] [Related]  

  • 16. Interventions to slow progression of myopia in children.
    Walline JJ; Lindsley KB; Vedula SS; Cotter SA; Mutti DO; Ng SM; Twelker JD
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004916. PubMed ID: 31930781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tropicamide and myopia progression.
    Iribarren R
    Ophthalmology; 2008 Jun; 115(6):1103-4; author reply 1104. PubMed ID: 18519078
    [No Abstract]   [Full Text] [Related]  

  • 18. Low concentration atropine and myopia: a narrative review of the evidence for United Kingdom based practitioners.
    Jawaid I; Saunders K; Hammond CJ; Dahlmann-Noor A; Bullimore MA
    Eye (Lond); 2024 Feb; 38(3):434-441. PubMed ID: 37717107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world outcomes of low-dose atropine therapy on myopia progression in an Australian cohort during the COVID-19 pandemic.
    Usmani E; Callisto S; Chan WO; Taranath D
    Clin Exp Ophthalmol; 2023 Nov; 51(8):775-780. PubMed ID: 37648227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year results of atropine 0.01% efficacy in the myopia control in a European population.
    Moriche-Carretero M; Revilla-Amores R; Gutiérrez-Blanco A; Moreno-Morillo FJ; Martinez-Perez C; Sánchez-Tena MÁ; Alvarez-Peregrina C
    Br J Ophthalmol; 2024 May; 108(5):715-719. PubMed ID: 37268328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.